ArticleInternational journal of clinical oncology2026
The role of surgical timing in survival of patients with spinal metastases.
Article in International journal of clinical oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundSpinal metastases commonly cause pain, neurological deterioration, and instability. Surgery is palliative, aiming to relieve symptoms and maintain oncologic treatment eligibility. Optimal surgical timing, however, remains debated.
methodsWe retrospectively analyzed 664 patients who underwent 760 operations for spinal metastases at Semmelweis University (2008-2022). Clinical data included demographics, comorbidities, primary tumor, neurological status, surgical approach, and timing of surgery relative to the symptom onset. Survival was assessed with both Kaplan-Meier and log-rank testing, with subgroup analyses by surgical timing and operative hours.
resultsPain (83%) and motor deficits (46%) were the most frequent symptoms. Lung, renal, breast, and hematologic cancers predominated. Median survival was 294 days; 30% exceeded two years. No survival advantage was detected for conventional acute surgical thresholds (≤ 48 h, ≤ 72 h, ≤ 1 week). Delays beyond one week correlated with reduced survival. Pain improved postoperatively in ~ 90% of cases, independent of timing. Severe preoperative motor dysfunction predicted poor survival and recovery, emphasizing the need for urgent surgery in this subgroup. Procedures during working hours were associated with superior postoperative symptom control (OR 3.3, p = 0.003), though survival outcomes were unchanged.
conclusionsSurgical management of spinal metastases provides consistent pain relief. Urgent intervention is critical in patients with progressive motor deficits, whereas multidisciplinary preoperative optimization is preferable in others. Operations during working hours yield better symptomatic outcomes, but survival remains primarily determined by the oncologic disease burden. Prospective multicenter studies are warranted to refine timing guidelines.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.